CAR-T Label Update Could Address Medicare Coverage Challenges, FDA’s Gottlieb Suggests
Executive Summary
Medicare’s current approach to inpatient CAR-T reimbursement in 2019 would lead to an $186,500 shortfall for providers per patient, stakeholders estimate.
You may also be interested in...
Could Outpatient Cell Therapies Provide Way Out Of Bundled Payment Trap?
Giving cell therapies as outpatient rather than inpatient treatments could be a way around the need for bundled payments, but it’s not universally applicable.
Gottlieb Shifts From Regulatory To Reimbursement Focus In One Of First Post-Commissioner Appearances
CAR-T reimbursement is concern for former US FDA commissioner Scott Gottlieb in speech at the National Press Club.
Medicare Weighing Higher Add-On Payments For New Drugs, Including CAR-T
Change would increase maximum new technology add-on payments from 50% to 65% of costs.